We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+5.59%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$6.62B
AUM Growth
+$2.6B
Cap. Flow
+$2.42B
Cap. Flow %
36.6%
Top 10 Hldgs %
33.44%
Holding
1,616
New
677
Increased
146
Reduced
99
Closed
525

Sector Composition

Rank Sector Weight
1 Technology 9.84%
2 Financials 7.68%
3 Consumer Discretionary 5.98%
4 Healthcare 5.66%
5 Communication Services 4.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PXLW icon
926
Pixelworks
PXLW
$37.9M
$58K ﹤0.01%
+1,422
New +$55.8K
BETRW icon
927
Better Home & Finance Warrant
BETRW
$2.51M
$57K ﹤0.01%
+33,309
New +$48K
KRMD icon
928
KORU Medical Systems
KRMD
$186M
$57K ﹤0.01%
+12,366
New +$48.5K
LCI
929
DELISTED
Lannett Company, Inc.
LCI
$57K ﹤0.01%
+3,065
New +$58.8K
TCDA
930
DELISTED
Tricida, Inc. Common Stock
TCDA
$57K ﹤0.01%
+13,309
New +$63.5K
FXI icon
931
CALL
iShares China Large-Cap ETF
FXI
$4.22B
$56K ﹤0.01%
+15,000
New +$693K
KURIW
932
DELISTED
Alkuri Global Acquisition Corp Warrant
KURIW
$56K ﹤0.01%
+38,200
New +$42.2K
ASMB icon
933
Assembly Biosciences
ASMB
$517M
$55K ﹤0.01%
+1,185
New +$58.7K
CFIVW
934
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$55K ﹤0.01%
+50,000
New +$46.8K
EMBKW
935
DELISTED
Embark Technology, Inc. Warrants
EMBKW
$55K ﹤0.01%
33,332
AAPL icon
936
PUT
Apple
AAPL
$4.93T
$54K ﹤0.01%
+12,392
New +$1.61M
GNPX icon
937
Genprex
GNPX
$4.01M
0
EVFM
938
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$54K ﹤0.01%
+3,175
New +$60.2K
CRBP icon
939
Corbus Pharmaceuticals
CRBP
$170M
$53K ﹤0.01%
+974
New +$54.1K
CBIO
940
Crescent Biopharma
CBIO
$632M
$53K ﹤0.01%
+229
New +$58.3K
FRWAW
941
DELISTED
PWP Forward Acquisition Corp. I Warrant
FRWAW
$53K ﹤0.01%
+50,000
New +$39.9K
CCV.WS
942
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$52K ﹤0.01%
+25,000
New +$38.1K
OSG
943
DELISTED
Overseas Shipholding Group Inc.
OSG
$51K ﹤0.01%
+24,375
New +$54.9K
NSTC.WS
944
DELISTED
Northern Star Investment Corp. III Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTC.WS
$51K ﹤0.01%
+41,666
New +$44.7K
ASPCW
945
DELISTED
Alpha Capital Acquisition Co Warrant
ASPCW
$51K ﹤0.01%
+62,500
New +$39.2K
APGB.WS
946
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$50K ﹤0.01%
+40,000
New +$43K
PNTM.WS
947
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$50K ﹤0.01%
50,000
ANAC.WS
948
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
$50K ﹤0.01%
+50,000
New +$42.7K
LJPC
949
DELISTED
La Jolla Pharmaceutical Company
LJPC
$49K ﹤0.01%
+11,515
New +$49.3K
AQST icon
950
Aquestive Therapeutics
AQST
$471M
$48K ﹤0.01%
+12,090
New +$48.3K

Similar funds

LMR Partners's Q2 2021 Portfolio in Review

As of Q2 2021, LMR Partners held 1,616 positions worth $6.62B, up 65% from $4.02B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

LMR Partners deployed $2.42B of net new capital in Q2 2021, opening 677 new positions and adding to 146 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 2,370,000 shares worth $1.01B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Baidu, an estimated $36M trimmed.

  • LMR Partners's largest Q2 2021 buy was State Street SPDR S&P 500 ETF Trust: 2,370,000 shares worth $1.01B.
  • LMR Partners added most to Discovery, Inc. Series C Common Stock in Q2 2021, an estimated $68.9M increase.
  • LMR Partners's biggest Q2 2021 reduction was Baidu, cutting an estimated $36M.
  • LMR Partners fully exited Corelogic, Inc. in Q2 2021, selling an estimated $64.4M.
  • LMR Partners's ten largest holdings make up 33% of its $6.62B portfolio in Q2 2021.
  • LMR Partners opened 677 new positions and closed 525 in Q2 2021.
  • LMR Partners's portfolio value rose 65% quarter-over-quarter to $6.62B.

Based on LMR Partners's 13F filing for Q2 2021, filed 16 Aug 2021.